303 related articles for article (PubMed ID: 19168847)
1. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis.
Cassidy FH; Yokoo T; Aganovic L; Hanna RF; Bydder M; Middleton MS; Hamilton G; Chavez AD; Schwimmer JB; Sirlin CB
Radiographics; 2009; 29(1):231-60. PubMed ID: 19168847
[TBL] [Abstract][Full Text] [Related]
2. Hepatic MR imaging for in vivo differentiation of steatosis, iron deposition and combined storage disorder: single-ratio in/opposed phase analysis vs. dual-ratio Dixon discrimination.
Bashir MR; Merkle EM; Smith AD; Boll DT
Eur J Radiol; 2012 Feb; 81(2):e101-9. PubMed ID: 21330083
[TBL] [Abstract][Full Text] [Related]
3. Quantification of liver fat with magnetic resonance imaging.
Reeder SB; Sirlin CB
Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):337-57, ix. PubMed ID: 21094444
[TBL] [Abstract][Full Text] [Related]
4. Pilot study assessing differentiation of steatosis hepatis, hepatic iron overload, and combined disease using two-point dixon MRI at 3 T: in vitro and in vivo results of a 2D decomposition technique.
Boll DT; Marin D; Redmon GM; Zink SI; Merkle EM
AJR Am J Roentgenol; 2010 Apr; 194(4):964-71. PubMed ID: 20308498
[TBL] [Abstract][Full Text] [Related]
5. MR fat fraction mapping: a simple biomarker for liver steatosis quantification in nonalcoholic fatty liver disease patients.
Leitão HS; Paulino C; Rodrigues D; Gonçalves SI; Marques C; Carvalheiro M; Geraldes CF; Caseiro-Alves F
Acad Radiol; 2013 Aug; 20(8):957-61. PubMed ID: 23830602
[TBL] [Abstract][Full Text] [Related]
6. Imaging-based quantification of hepatic fat: methods and clinical applications.
Ma X; Holalkere NS; Kambadakone R A; Mino-Kenudson M; Hahn PF; Sahani DV
Radiographics; 2009; 29(5):1253-77. PubMed ID: 19755595
[TBL] [Abstract][Full Text] [Related]
7. Quantification of hepatic macrosteatosis in living, related liver donors using T1-independent, T2*-corrected chemical shift MRI.
Joe E; Lee JM; Kim KW; Lee KB; Kim SJ; Baek JH; Shin CI; Suh KS; Yi NJ; Han JK; Choi BI
J Magn Reson Imaging; 2012 Nov; 36(5):1124-30. PubMed ID: 22761083
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities.
Guaraldi G; Besutti G; Stentarelli C; Zona S; Nocetti L; Loria P; Ballestri S; Losi L; Torricelli P; Ligabue G
Antivir Ther; 2012; 17(6):965-71. PubMed ID: 22766513
[TBL] [Abstract][Full Text] [Related]
9. Evaluating childhood obesity: magnetic resonance-based quantification of abdominal adipose tissue and liver fat in children.
Raschpichler MC; Sorge I; Hirsch W; Mende M; Sergeyev E; Kruber D; Koerner A; Schick F
Rofo; 2012 Apr; 184(4):324-32. PubMed ID: 22322443
[TBL] [Abstract][Full Text] [Related]
10. Quantification of fat infiltration in oculopharyngeal muscular dystrophy: comparison of three MR imaging methods.
Gloor M; Fasler S; Fischmann A; Haas T; Bieri O; Heinimann K; Wetzel SG; Scheffler K; Fischer D
J Magn Reson Imaging; 2011 Jan; 33(1):203-10. PubMed ID: 21182140
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
[TBL] [Abstract][Full Text] [Related]
12. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging.
Schuchmann S; Weigel C; Albrecht L; Kirsch M; Lemke A; Lorenz G; Warzok R; Hosten N
Eur J Radiol; 2007 Jun; 62(3):416-22. PubMed ID: 17267159
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging.
Borra RJ; Salo S; Dean K; Lautamäki R; Nuutila P; Komu M; Parkkola R
Radiology; 2009 Jan; 250(1):130-6. PubMed ID: 19017926
[TBL] [Abstract][Full Text] [Related]
15. Quantification of hepatic steatosis: a comparison of computed tomography and magnetic resonance indices in candidates for living liver donation.
Maruzzelli L; Parr AJ; Miraglia R; Tuzzolino F; Luca A
Acad Radiol; 2014 Apr; 21(4):507-13. PubMed ID: 24594420
[TBL] [Abstract][Full Text] [Related]
16. Comparison between multi-echo T2* with and without fat saturation pulse for quantification of liver iron overload.
Sanches-Rocha L; Serpa B; Figueiredo E; Hamerschlak N; Baroni R
Magn Reson Imaging; 2013 Dec; 31(10):1704-8. PubMed ID: 23978552
[TBL] [Abstract][Full Text] [Related]
17. Hyperechoic liver nodules: characterization with proton fat-water chemical shift MR imaging.
Martín J; Puig J; Falcó J; Donoso L; Rué M; Sentís M; Darnell A; Musulén E
Radiology; 1998 May; 207(2):325-30. PubMed ID: 9577476
[TBL] [Abstract][Full Text] [Related]
18. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.
Guiu B; Petit JM; Loffroy R; Ben Salem D; Aho S; Masson D; Hillon P; Krause D; Cercueil JP
Radiology; 2009 Jan; 250(1):95-102. PubMed ID: 19092092
[TBL] [Abstract][Full Text] [Related]
19. Liver fat and iron at in-phase and opposed-phase MR imaging.
Alústiza JM; Castiella A
Radiology; 2008 Feb; 246(2):641. PubMed ID: 18227554
[No Abstract] [Full Text] [Related]
20. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques.
Schwenzer NF; Machann J; Martirosian P; Stefan N; Schraml C; Fritsche A; Claussen CD; Schick F
Invest Radiol; 2008 May; 43(5):330-7. PubMed ID: 18424954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
